Experiment 644720
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | IZER,J: HAUTMANN,C:. (1999). COMPARISON OF TWO DOSAGES OF GINKGO BILOBA EXTRACT EGB 761 IN PATIENTS WITH PERIPHERAL ARTERIAL OCCULSIVE DISEASE FONTAINE'S STAGE IIB.. 49(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | RANDOMIZED DOUBLE-BLIND MULTICENTRIC PARALLEL-GROUP TRIAL WAS CONDUCTED AT 3 STUDY CENTERS BETWEEN MAY 1994 AND SEPTEMBER 1996 TO COMPARE 2 DOSAGES OF GINKGO BILOBA EXTRACT EGB761 IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE'S STAGE IIB. THE PRIMARY EFFICACY CRITERION WAS THE DIFFERENCE OF THE PAIN-FREE WALKING DISTANCE BETWEEN THE START OF TREATMENT AND AFTER 24 WEEKS MEASURED ON TREATMENT MEASURED ON A TREADMILL UNDER STANDARDISED CONDITIONS. BOTH DOSAGE REGIMENS LED TO IMPROVEMENT OF THE PAIN-FREE WALKING DISTANCE AFTER 24 WEEKS OF TREATMENT. THE SUPERIORITY OF THE HIGHER DOSAGE OVER THE STANDARD DOSAGE WAS STATISTICALLY SIGNIFICANT. A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 120.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ACETONE EXT |
| Gender | GIVEN TO BOTH SEXES |